Navigation Links
Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results
Date:9/14/2009

BALTIMORE, Sept. 14 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the first quarter ended July 31, 2009. Full details of the Company's financial results are available in the Company's Form 10-Q at www.championsbiotechnology.com.

Total revenues for the first quarter of 2010 were $962,000 as compared to $673,000 in the first quarter of 2009, an increase of 43%. This increase was derived from the Company's Personalized Oncology business, which generated revenues of $899,000 for the first quarter of 2010 compared to $616,000 in the comparable quarter of last year. This increase consisted of increases in Personalized Oncology Tumorgraft studies and vaccines, partially offset by a decrease in revenues from physician panels. Preclinical eValuation revenues for three months ended July 31, 2009, and 2008 were $63,000 and $57,000, respectively.

Costs of Personalized Oncology services for the first quarter of 2010 was $634,000 as compared to $226,000 in the first quarter of 2009, an increase of 181%. The cost of Personalized Oncology services increased due to an increase in the number of Tumorgraft studies, which have higher expenses (lower gross margins) than revenues derived from our physician panels. In addition, the Company recognized the costs of a vaccine development study which required additional up front expenses. Cost of Preclinical eValuation services for the three months ended July 31, 2009, and 2008 were $34,000 and $34,000, respectively.

Research and Development expenses for the first
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
2. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
3. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
4. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
5. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
6. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
7. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
8. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
9. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
10. Champions Biotechnology Reports Fiscal 2009 Full-Year Financial Results
11. Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... SEATTLE , March 3, 2015 Adaptive ... Group CFO, is joining its Board of Director as ... financial officer at Zillow Group, Chad oversees all finance, ... Chad built the company,s core finance, treasury and accounting ... IPO and nine acquisitions. In 2013, he was named ...
(Date:3/3/2015)... FALLS, N.J. , March 3, 2015  Regenicin, ... biotechnology company specializing in the development of and commercialization ... damaged tissues and organs, announced today that it has ... Agreement with Amarantus Bioscience Holdings, Inc. (OTC Bulletin Board: ... under the Agreement, Amarantus made the final payments due ...
(Date:3/3/2015)... 03, 2015 HubCast® Inc. ( http://www.hubcast.com ... announced the expansion of its Global Print Supply Chain ... 850 the world’s largest cities across 75 countries globally. ... 137 countries providing global enterprises ease, speed, reach, quality, ... from online order to real-world delivery at postal address ...
(Date:3/3/2015)... , March 3, 2015  Rosa & Co. LLC, ... modeling and simulation research, today announced it has two ... Society for Clinical Pharmacology and Therapeutics meeting in ...   Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   ... present a poster describing a quantitative systems pharmacology approach ...
Breaking Biology Technology:Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3HubCast Expands Global Print Supply Chain: Launches New Product Suite 2HubCast Expands Global Print Supply Chain: Launches New Product Suite 3HubCast Expands Global Print Supply Chain: Launches New Product Suite 4Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3
... , , ... , A fast and accurate method ... , , , This Application Note,addresses the ... quantity,and lifespan. Using the Agilent,2100 bioanalyzer and Cell Fluorescence,LabChip kit the ...
... , , , , ... Cell Death Detection Kit has been designed as a precise, fast, and simple, ... the single-cell level in tissues. It is based on the so-called TUNEL, ... , , , ...
... , , ... , , Detection of early apoptotic events has ... a variety of,diseases and pathological conditions accompanied,either by cell accumulation (e.g., cancer) or ... , , , One ...
Cached Biology Technology:Flow cytometric analysis of human,primary cells using the Agilent 2100,bioanalyzer and on-chip staining 2Flow cytometric analysis of human,primary cells using the Agilent 2100,bioanalyzer and on-chip staining 3In Situ Cell Death Detection Kit 2A Further Step in Understanding Apoptosis, Direct Detection of PARP Cleavage 2A Further Step in Understanding Apoptosis, Direct Detection of PARP Cleavage 3
(Date:2/5/2015)... VIEW, Calif. , Feb. 3, 2015 /PRNewswire/ ... printer technology, demand from industries such as consumer ... global market for surface mount technology (SMT) screen ... equipment to automatic control will push the adoption ... dispensers will remain steady as glue dispensers are ...
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to ... State of Washington,s Department of Licensing, in ... central issuance system for driver,s licenses and identification cards to ... and development will start in January 2015, with enrollment and ...
(Date:1/22/2015)... , Jan. 13, 2015  Today, FreeWavz ( ... launched its crowdfunding campaign on Fundable, https://www.fundable.com/freewavz ... build of production capacity to meet customer demand. ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Valid USA Signs Contract For Washington Driver's License Issuance 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... Current health care is not as safe as it ... rzteblatt International (Dtsch Arztebl Int 2010; 107[6]: 92-9), ... adverse events, as well as measures to ensure better ... The German Coalition for,Patient Safety (Aktionsbndnis Patientensicherheit) estimates that ...
... of Biology has recently returned from a meeting of the ... Crocusbank project centres round saffron as a spice and is ... is to improve saffron production, a crop which is grown ... both sustainable and of very high value. The condiment is ...
... Heidelberg, 4 March 2010 The thousands of bacteria, fungi ... contributors to our good health. They break down toxins, manufacture ... against invaders. A study published today in Nature ... outnumber previous estimates for the whole of the human body. ...
Cached Biology News:Leicester's internationally acclaimed genetics research involved in project into saffron production 2Bacterial balance that keeps us healthy 2
Apoptosis Detection Systems and Reagents...
Bovine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11:...
Anti-Mouse Qa.m8, Ascites (Clone 5035-24.1) (mouse IgG3)...
... and TriEx Insect Cell Medium are recommended ... This cell/medium combination has been selected based ... protein expression levels observed specifically with baculoviruses ... that our Ready-Plaque Sf9 Cells and BacVector ...
Biology Products: